Adaptive immune response to viral infections in the central nervous system

Handbook of Clinical Neurology

Volumn 123, Issue , 2014, Pages 225-247

  Libbey, Jane E ^a   Fujinami, Robert S ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Adaptive immune response; Cellular immunity; Central nervous system; Humoral immunity; Immune privilege; Immunopathology; Neurotropic viruses; Viral clearance; Viral infection; Viral latency; Viral persistence

Indexed keywords

ADAPTIVE IMMUNITY; ANIMAL; ARTICLE; CELLULAR IMMUNITY; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM INFECTION; HUMAN; HUMORAL IMMUNITY; IMMUNE PRIVILEGE; IMMUNOLOGY; IMMUNOPATHOLOGY; NEUROTROPIC VIRUSES; VIRAL CLEARANCE; VIRAL LATENCY; VIRAL PERSISTENCE; VIRUS INFECTION;

ADAPTIVE IMMUNE RESPONSE; CELLULAR IMMUNITY; CENTRAL NERVOUS SYSTEM; HUMORAL IMMUNITY; IMMUNE PRIVILEGE; IMMUNOPATHOLOGY; NEUROTROPIC VIRUSES; VIRAL CLEARANCE; VIRAL INFECTION; VIRAL LATENCY; VIRAL PERSISTENCE;

ADAPTIVE IMMUNITY; ANIMALS; CENTRAL NERVOUS SYSTEM VIRAL DISEASES; HUMANS;

EID: 84903942166     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-444-53488-0.00010-9     Document Type: Chapter

References (206)

1. Aggarwal S., Ghilardi N., Xie M.-H., et al. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem 2003, 278:1910-1914.
2. Alter A., Duddy M., Hebert S., et al. Determinants of human B cell migration across brain endothelial cells. J Immunol 2003, 170:4497-4505.
3. Amlie-Lefond C., Kleinschmidt-DeMasters B.K., Mahalingam R., et al. The vasculopathy of varicella-zoster virus encephalitis. Ann Neurol 1995, 37:784-790.
4. Appay V., Zaunders J.J., Papagno L., et al. Characterization of CD4+ CTLs ex vivo. J Immunol 2002, 168:5954-5958.
5. Asquith B., Bangham C.R.M. How does HTLV-I persist despite a strong cell-mediated immune response?. Trends Immunol 2008, 29:4-11.
6. Babbitt B.P., Allen P.M., Matsueda G., et al. Binding of immunogenic peptides to Ia histocompatibility molecules. Nature 1985, 317:359-361.
7. Bailey S.L., Carpentier P.A., McMahon E.J., et al. Innate and adaptive immune responses of the central nervous system. Crit Rev Immunol 2006, 26:149-188.
8. Banks W.A., Erickson M.A. The blood-brain barrier and immune function and dysfunction. Neurobiol Dis 2010, 37:26-32.
9. Baringer J.R. Herpes simplex infections of the nervous system. Neurol Clin 2008, 26:657-674.
10. Bechmann I., Galea I., Perry V.H. What is the blood-brain barrier (not)?. Trends Immunol 2007, 28:5-11.
11. Becker K. Innate and adaptive immune responses in CNS disease. Clin Neurosci Res 2006, 6:227-236.
12. Berg B.O. Neurology - epitomes of progress: progressive rubella panencephalitis. West J Med 1977, 127:134.
13. Binder G.K., Griffin D.E. Immune-mediated clearance of virus from the central nervous system. Microbes Infect 2003, 5:439-448.
14. Bjorkman P.J., Saper M.A., Samraoui B., et al. Structure of the human class I histocompatibility antigen, HLA-A2. Nature 1987, 329:506-512.
15. Bjorkman P.J., Saper M.A., Samraoui B., et al. The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature 1987, 329:512-518.
16. Boackle S.A., Morris M.A., Holers V.M., et al. Complement opsonization is required for presentation of immune complexes by resting peripheral blood B cells. J Immunol 1998, 161:6537-6543.
17. Brooks D.G., Trifilo M.J., Edelmann K.H., et al. Interleukin-10 determines viral clearance or persistence in vivo. Nat Med 2006, 12:1301-1309.
18. Brooks D.G., Ha S.J., Elsaesser H., et al. IL-10 and PD-L1 operate through distinct pathways to suppress T-cell activity during persistent viral infection. Proc Natl Acad Sci U S A 2008, 105:20428-20433.
19. Brooks D.G., Lee A.M., Elsaesser H., et al. IL-10 blockade facilitates DNA vaccine-induced T cell responses and enhances clearance of persistent virus infection. J Exp Med 2008, 205:533-541.
20. Burdeinick-Kerr R., Griffin D.E. Gamma interferon-dependent, noncytolytic clearance of sindbis virus infection from neurons in vitro. J Virol 2005, 79:5374-5385.
21. Burgoon M.P., Caldas Y.A., Keays K.M., et al. Recombinant antibodies generated from both clonal and less abundant plasma cell immunoglobulin G sequences in subacute sclerosing panencephalitis brain are directed against measles virus. J Neurovirol 2006, 12:398-402.
22. Cardona A.E., Li M., Liu L., et al. Chemokines in and out of the central nervous system: much more than chemotaxis and inflammation. J Leukoc Biol 2008, 84:587-594.
23. + T cells into the central nervous system by professional antigen-presenting cells. Am J Pathol 1999, 154:481-494.
24. Carson M.J., Doose J.M., Melchior B., et al. CNS immune privilege: hiding in plain sight. Immunol Rev 2006, 213:48-65.
25. Chavarria A., Alcocer-Varela J. Is damage in central nervous system due to inflammation?. Autoimmun Rev 2004, 3:251-260.
26. Chiba Y., Horino K., Umetsu M., et al. Virus excretion and antibody response in saliva in natural mumps. Tohoku J Exp Med 1973, 111:229-238.
27. Clifford D.B., DeLuca A., Simpson D.M., et al. Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases. Lancet Neurol 2010, 9:438-446.
28. Columba-Cabezas S., Serafini B., Ambrosini E., et al. Lymphoid chemokines CCL19 and CCL21 are expressed in the central nervous system during experimental autoimmune encephalomyelitis: implications for the maintenance of chronic neuroinflammation. Brain Pathol 2003, 13:38-51.
29. Conrady C.D., Drevets D.A., Carr D.J.J. Herpes simplex type I (HSV-1) infection of the nervous system: Is an immune response a good thing?. J Neuroimmunol 2010, 220:1-9.
30. Cserr H.F., Knopf P.M. Cervical lymphatics, the blood-brain barrier and the immunoreactivity of the brain: a new view. Immunol Today 1992, 13:507-512.
31. Cserr H.F., Harling-Berg C.J., Knopf P.M. Drainage of brain extracellular fluid into blood and deep cervical lymph and its immunological significance. Brain Pathol 1992, 2:269-276.
32. Davenport M.P., Price D.A., McMichael A.J. The T cell repertoire in infection and vaccination: implications for control of persistent viruses. Curr Opin Immunol 2007, 19:294-300.
33. de la Torre J.C., Mallory M., Brot M., et al. Viral persistence in neurons alters synaptic plasticity and cognitive functions without destruction of brain cells. Virology 1996, 220:508-515.
34. Defrance T., Casamayor-Pallejà M., Krammer P.H. The life and death of a B cell. Adv Cancer Res 2002, 86:195-225.
35. Derfuss T., Segerer S., Herberger S., et al. Presence of HSV-1 immediate early genes and clonally expanded T-cells with a memory effector phenotype in human trigeminal ganglia. Brain Pathol 2007, 17:389-398.
36. Derfuss T., Arbusow V., Strupp M., et al. The presence of lytic HSV-1 transcripts and clonally expanded T cells with a memory effector phenotype in human sensory ganglia. Ann N Y Acad Sci 2009, 1164:300-304.
37. Diamond M.S., Mehlhop E., Oliphant T., et al. The host immunologic response to West Nile encephalitis virus. Front Biosci 2009, 14:3024-3040.
38. Ellis R. HIV and antiretroviral therapy: impact on the central nervous system. Prog Neurobiol 2010, 91:185-187.
39. Engelhardt B. Regulation of immune cell entry into the central nervous system. Results Probl Cell Differ 2006, 43:259-280.
40. Engelhardt B. The blood-central nervous system barriers actively control immune cell entry into the central nervous system. Curr Pharm Des 2008, 14:1555-1565.
41. Frey T.K. Neurological aspects of rubella virus infection. Intervirology 1997, 40:167-175.
42. Fujinami R.S., Oldstone M.B.A. Alterations in expression of measles virus polypeptides by antibody: molecular events in antibody-induced antigenic modulation. J Immunol 1980, 125:78-85.
43. Fujinami R.S., Oldstone M.B.A. Antigenic modulation: a mechanism of viral persistence. Prog Brain Res 1983, 59:105-111.
44. Fujinami R.S., Oldstone M.B.A., Wroblewska Z., et al. Molecular mimicry in virus infection: crossreaction of measles virus phosphoprotein or of herpes simplex virus protein with human intermediate filaments. Proc Natl Acad Sci U S A 1983, 80:2346-2350.
45. Fujinami R.S., Norrby E., Oldstone M.B.A. Antigenic modulation induced by monoclonal antibodies: antibodies to measles virus hemagglutinin alters expression of other viral polypeptides in infected cells. J Immunol 1984, 132:2618-2621.
46. Furukawa Y., Tara M., Izumo S., et al. HTLV-I viral escape and host genetic changes in the development of adult T cell leukemia. Int J Cancer 2006, 118:381-387.
47. Galea I., Bechmann I., Perry V.H. What is immune privilege (not)?. Trends Immunol 2007, 28:12-18.
48. Gilden D.H. Slow virus diseases of the CNS. 1. Subacute sclerosing panencephalitis, progressive rubella panencephalitis, and progressive multifocal leukoencephalopathy. Postgrad Med 1983, 73:99-108.
49. Gilden D.H., Murray R.S., Wellish M., et al. Chronic progressive varicella-zoster virus encephalitis in an AIDS patient. Neurology 1988, 38:1150-1153.
50. Glass W.G., Lim J.K., Cholera R., et al. Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection. J Exp Med 2005, 202:1087-1098.
51. Goff S.P. Retroviridae: The retroviruses and their replication. Fields virology 2007, 1999-2069. Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia. 5th edn. D.M. Knipe, P.M. Howley, D.E. Griffin (Eds.).
52. Goldmann J., Kwidzinski E., Brandt C., et al. T cells traffic from brain to cervical lymph nodes via the cribroid plate and the nasal mucosa. J Leukoc Biol 2006, 80:797-801.
53. Gordon L.B., Knopf P.M., Cserr H.F. Ovalbumin is more immunogenic when introduced into brain or cerebrospinal fluid than into extracerebral sites. J Neuroimmunol 1992, 40:81-87.
54. Grant C., Barmak K., Alefantis T., et al. Human T cell leukemia virus type I and neurologic disease: events in bone marrow, peripheral blood, and central nervous system during normal immune surveillance and neuroinflammation. J Cell Physiol 2002, 190:133-159.
55. Griffin D.E. Immune responses to RNA-virus infections of the CNS. Nat Rev Immunol 2003, 3:493-502.
56. Griffin D.E. Alphaviruses. Fields virology 2007, 1023-1067. Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia. 5th edn. D.M. Knipe, P.M. Howley, D.E. Griffin (Eds.).
57. Griffin D.E. Emergence and re-emergence of viral diseases of the central nervous system. Prog Neurobiol 2010, 91:95-101.
58. Grubor-Bauk B., Simmons A., Mayrhofer G., et al. Impaired clearance of herpes simplex virus type 1 from mice lacking CD1d or NKT cells expressing the semivariant Vα14-Jα281 TCR. J Immunol 2003, 170:1430-1434.
59. Grubor-Bauk B., Arthur J.L., Mayrhofer G. Importance of NKT cells in resistance to herpes simplex virus, fate of virus-infected neurons, and level of latency in mice. J Virol 2008, 82:11073-11083.
60. Haginoya K., Ike K., Iinuma K., et al. Chronic progressive mumps virus encephalitis in a child. Lancet 1995, 346:50.
61. Hämmerling G.J., Masuda T., McDevitt H.O. Genetic control of the immune response. Frequency and characteristics of antigen-binding cells in high and low responder mice. J Exp Med 1973, 137:1180-1200.
62. Happel K.I., Zheng M., Young E., et al. Cutting edge: roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection. J Immunol 2003, 170:4432-4436.
63. Harling-Berg C., Knopf P.M., Merriam J., et al. Role of cervical lymph nodes in the systemic humoral immune response to human serum albumin microinfused into rat cerebrospinal fluid. J Neuroimmunol 1989, 25:185-193.
64. Haskins K., Kubo R., White J., et al. The major histocompatibility complex-restricted antigen receptor on T cells. I. Isolation with a monoclonal antibody. J Exp Med 1983, 157:1149-1169.
65. Hawke S., Stevenson P.G., Freeman S., et al. Long-term persistence of activated cytotoxic T lymphocytes after viral infection of the central nervous system. J Exp Med 1998, 187:1575-1582.
66. Hickey W.F., Kimura H. Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science 1988, 239:290-292.
67. Hirsch R.L., Griffin D.E., Johnson R.T., et al. Cellular immune responses during complicated and uncomplicated measles virus infections of man. Clin Immunol Immunopathol 1984, 31:1-12.
68. Hollander H., Stringari S. Human immunodeficiency virus-associated meningitis. Clinical course and correlations. Am J Med 1987, 83:813-816.
69. Hooper D.C., Sauder C., Scott G.S., et al. Immunopathology and immunoprotection in CNS virus infections: mechanisms of virus clearance from the CNS. Curr Top Microbiol Immunol 2002, 265:163-182.
70. Hüfner K., Derfuss T., Herberger S., et al. Latency of α-herpes viruses is accompanied by a chronic inflammation in human trigeminal ganglia but not in dorsal root ganglia. J Neuropathol Exp Neurol 2006, 65:1022-1030.
71. Hviid A., Rubin S., Mühlemann K. Mumps. Lancet 2008, 371:932-944.
72. Imperiale M.J., Major E.O. Polyomaviruses. Fields virology 2007, 2263-2298. Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia. 5th edn. D.M. Knipe, P.M. Howley, D.E. Griffin (Eds.).
73. Jahrling P.B., Hesse R.A., Anderson A.O., et al. Opsonization of alphaviruses in hamsters. J Med Virol 1983, 12:1-16.
74. Jamieson B.D., Somasundaram T., Ahmed R. Abrogation of tolerance to a chronic viral infection. J Immunol 1991, 147:3521-3529.
75. Jeang K.T. HTLV-1 and adult T-cell leukemia: insights into viral transformation of cells 30 years after virus discovery. J Formos Med Assoc 2010, 109:688-693.
76. Johnson R.T. The pathogenesis of acute viral encephalitis and postinfectious encephalomyelitis. J Infect Dis 1987, 155:359-364.
77. Johnson R.T., Griffin D.E., Hirsch R., et al. Measles encephalitis. Clin Exp Neurol 1983, 19:13-16.
78. Johnson R.T., Griffin D.E., Hirsch R.L., et al. Measles encephalomyelitis - clinical and immunologic studies. N Engl J Med 1984, 310:137-141.
79. Joly E., Mucke L., Oldstone M.B.A. Viral persistence in neurons explained by lack of major histocompatibility class I expression. Science 1991, 253:1283-1285.
80. Julkunen I., Lehtokoski-Lehtiniemi E., Koskiniemi M., et al. Elevated mumps antibody titers in the cerebrospinal fluid suggesting chronic mumps virus infection in the central nervous system. Pediatr Infect Dis 1985, 4:99.
81. Kägi D., Hengartner H. Different roles for cytotoxic T cells in the control of infections with cytopathic versus noncytopathic viruses. Curr Opin Immunol 1996, 8:472-477.
82. Kägi D., Seiler P., Pavlovic J., et al. The roles of perforin- and Fas-dependent cytotoxicity in protection against cytopathic and noncytopathic viruses. Eur J Immunol 1995, 25:3256-3262.
83. Kang S.S., McGavern D.B. Lymphocytic choriomeningitis infection of the central nervous system. Front Biosci 2008, 13:4529-4543.
84. Kang S.S., McGavern D.B. Inflammation on the mind: Visualizing immunity in the central nervous system. Curr Top Microbiol Immunol 2009, 334:227-263.
85. Kaplan H.J., Niederkorn J.Y. Regional immunity and immune privilege. Chem Immunol Allergy 2007, 92:11-26.
86. Karman J., Ling C., Sandor M., et al. Dendritic cells in the initiation of immune responses against central nervous system-derived antigens. Immunol Lett 2004, 92:107-115.
87. Karman J., Ling C., Sandor M., et al. Initiation of immune responses in brain is promoted by local dendritic cells. J Immunol 2004, 173:2353-2361.
88. + T cells and major histocompatibility complex class I expression in the central nervous system of mice infected with neurovirulent Sindbis virus. J Virol 2000, 74:6117-6125.
89. Klein R.S., Diamond M.S. Immunological headgear: antiviral immune responses protect against neuroinvasive West Nile virus. Trends Mol Med 2008, 14:286-294.
90. + T-cell recruitment and control of West Nile virus encephalitis. J Virol 2005, 79:11457-11466.
91. Kleinschmidt-DeMasters B.K., Tyler K.L. Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis. N Engl J Med 2005, 353:369-374.
92. Kleinschmidt-DeMasters B.K., Amlie-Lefond C., Gilden D.H. The patterns of varicella zoster virus encephalitis. Hum Pathol 1996, 27:927-938.
93. Knopf P.M., Harling-Berg C.J., Cserr H.F., et al. Antigen-dependent intrathecal antibody synthesis in the normal rat brain: tissue entry and local retention of antigen-specific B cells. J Immunol 1998, 161:692-701.
94. Koralnik I.J. Overview of the cellular immunity against JC virus in progressive multifocal leukoencephalopathy. J Neurovirol 2002, 8(Suppl 2):59-65.
95. Koralnik I.J. New insights into progressive multifocal leukoencephalopathy. Curr Opin Neurol 2004, 17:365-370.
96. + lymphocytes in the spinal cord from patients with HTLV-I-associated myelopathy. J Neuroimmunol 1994, 53:23-29.
97. + cells in HTLV type 1-asociated myelopathy/tropical spastic paraparesis: correlation with HTLV type 1 proviral load. AIDS Res Hum Retroviruses 2000, 16:1705-1709.
98. Kuroda M.J., Schmitz J.E., Charini W.A., et al. Emergence of CTL coincides with clearance of virus during primary simian immunodeficiency virus infection in rhesus monkeys. J Immunol 1999, 162:5127-5133.
99. Lacey S.F., Zhou W. Immune responses to BK and JC viruses in immunocompromised patients. Future Virol 2007, 2:255-266.
100. Lane T.E., Hardison J.L., Walsh K.B. Functional diversity of chemokines and chemokine receptors in response to viral infection of the central nervous system. Curr Top Microbiol Immunol 2006, 303:1-27.
101. Langer-Gould A., Atlas S.W., Green A.J., et al. Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. N Engl J Med 2005, 353:375-381.
102. Lauterbach H., Truong P., McGavern D.B. Clearance of an immunosuppressive virus from the CNS coincides with immune reanimation and diversification. Virol J 2007, 4:53.
103. Lawrence D.M.P., Patterson C.E., Gales T.L., et al. Measles virus spread between neurons requires cell contact but not CD46 expression, syncytium formation, or extracellular virus production. J Virol 2000, 74:1908-1918.
104. Lawrence C.W., Ream R.M., Braciale T.J. Frequency, specificity, and sites of expansion of CD8+ T cells during primary pulmonary influenza virus infection. J Immunol 2005, 174:5332-5340.
105. Lederman S., Yellin M.J., Krichevsky A., et al. Identification of a novel surface protein on activated CD4+ T cells that induces contact-dependent B cell differentiation (help). J Exp Med 1992, 175:1091-1101.
106. Liu Y., Teige I., Birnir B., et al. Neuron-mediated generation of regulatory T cells from encephalitogenic T cells suppresses EAE. Nat Med 2006, 12:518-525.
107. Lukacher A.E., Braciale V.L., Braciale T.J. In vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific. J Exp Med 1984, 160:814-826.
108. Magnus T., Schreiner B., Korn T., et al. Microglial expression of the B7 family member B7 homolog 1 confers strong immune inhibition: implications for immune responses and autoimmunity in the CNS. J Neurosci 2005, 25:2537-2546.
109. Mäkelä O. Analogies between lymphocyte receptors and the resulting humoral antibodies. Transplant Rev 1970, 5:3-18.
110. Marra C.M., Maxwell C.L., Collier A.C., et al. Interpreting cerebrospinal fluid pleocytosis in HIV in the era of potent antiretroviral therapy. BMC Infect Dis 2007, 7:37.
111. + -T-cell expansion and trafficking following central nervous system infection. J Virol 2003, 77:2775-2778.
112. Martín J. Vaccine-derived poliovirus from long term excretors and the end game of polio eradication. Biologicals 2006, 34:117-122.
113. Masson D., Zamai M., Tschopp J. Identification of granzyme A isolated from cytotoxic T-lymphocyte-granules as one of the proteases encoded by CTL-specific genes. FEBS Lett 1986, 208:84-88.
114. McArthur J.C., Sipos E., Cornblath D.R., et al. Identification of mononuclear cells in CSF of patients with HIV infection. Neurology 1989, 39:66-70.
115. McFarland H.F., McFarlin D.E. The cellular immune response to virus infection. Handbook of clinical neurology 1989, 65-77. Elsevier Science, Amsterdam. P.J. Vinken, G.W. Bruyn, H.L. Klawans (Eds.).
116. McGavern D.B., Homann D., Oldstone M.B.A. T cells in the central nervous system: The delicate balance between viral clearance and disease. J Infect Dis 2002, 186(Suppl 2):S145-S151.
117. McIntyre B.W., Allison J.P. The mouse T cell receptor: structural heterogeneity of molecules of normal T cells defined by xenoantiserum. Cell 1983, 34:739-746.
118. + T lymphocytes is effected through the Fas/FasL, but not the perforin pathway. Eur J Immunol 2000, 30:3623-3633.
119. Mehlhop E., Diamond M.S. The molecular basis of antibody protection against West Nile virus. Curr Top Microbiol Immunol 2008, 317:125-153.
120. Mehta P.D., Thormar H., Kulczycki J., et al. Immune response in subacute sclerosing panencephalitis. Ann N Y Acad Sci 1994, 724:378-384.
121. Melchers F. Actions of BAFF in B cell maturation and its effects on the development of autoimmune disease. Ann Rheum Dis 2003, 62(Suppl 2):ii25-ii27.
122. Meuer S.C., Fitzgerald K.A., Hussey R.E., et al. Clonotypic structures involved in antigen-specific human T cell function. Relationship to the T3 molecular complex. J Exp Med 1983, 157:705-719.
123. Meuer S.C., Hodgdon J.C., Hussey R.E., et al. Antigen-like effects of monoclonal antibodies directed at receptors on human T cell clones. J Exp Med 1983, 158:988-993.
124. Miller R.J., Rostene W., Apartis E., et al. Chemokine action in the nervous system. J Neurosci 2008, 28:11792-11795.
125. Mohamed A.J., Ndumbe P., Hall A., et al. Independent evaluation of major barriers to interrupting poliovirus transmission - executive summary 2009, Available online at:. http://www.polioeradication.org/content/general/Polio_Evaluation_CON.pdf.
126. Mosmann T.R., Cherwinski H., Bond M.W., et al. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986, 136:2348-2357.
127. Mrass P., Weninger W. Immune cell migration as a means to control immune privilege: lessons from the CNS and tumors. Immunol Rev 2006, 213:195-212.
128. Nanan R., Rauch A., Kämpgen E., et al. A novel sensitive approach for frequency analysis of measles virus-specific memory T-lymphocytes in healthy adults with a childhood history of natural measles. J Gen Virol 2000, 81:1313-1319.
129. Naniche D., Garenne M., Rae C., et al. Decrease in measles virus-specific CD4 T cell memory in vaccinated subjects. J Infect Dis 2004, 190:1387-1395.
130. Nath A. Rubella. Clinical neurovirology 2003, 447-452. Marcel Dekker, New York. A. Nath, J.R. Berger (Eds.).
131. Nathanson N. The pathogenesis of poliomyelitis: what we don't know. Adv Virus Res 2008, 71:1-50.
132. Nathanson N., Ahmed R. Immune responses to viral infection. Viral pathogenesis and immunity 2007, 72-87. Academic Press/Elsevier, Amsterdam. 2nd edn. N. Nathanson, R. Ahmed, C.A. Biron (Eds.).
133. Nathanson N., Biron C.A. Innate immunity. Viral pathogenesis and immunity 2007, 59-71. Academic Press/Elsevier, Amsterdam. 2nd edn. N. Nathanson, R. Ahmed, C.A. Biron (Eds.).
134. Nathanson N., Gonzalez-Scarano F. Viral persistence. Viral pathogenesis and immunity 2007, 130-145. Academic Press/Elsevier, Amsterdam. 2nd edn. N. Nathanson, R. Ahmed, C.A. Biron (Eds.).
135. Nathanson N., Murphy F.A. The sequential steps in viral infection. Viral pathogenesis and immunity 2007, 14-26. Academic Press/Elsevier, Amsterdam. 2nd ed. N. Nathanson, R. Ahmed, C.A. Biron (Eds.).
136. Navia B.A., Cho E.-S., Petito C.K., et al. The AIDS dementia complex: II. Neuropathology. Ann Neurol 1986, 19:525-535.
137. Navia B.A., Jordan B.D., Price R.W. The AIDS dementia complex: I. Clinical features. Ann Neurol 1986, 19:517-524.
138. Noelle R.J., Roy M., Shepherd D.M., et al. A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells. Proc Natl Acad Sci U S A 1992, 89:6550-6554.
139. Okabe N., Hashimoto G., Abo T., et al. Characterization of the human peripheral blood effector cells mediating antibody-dependent cell-mediated cytotoxicity against respiratory syncytial virus. Clin Immunol Immunopathol 1983, 27:200-209.
140. Oldstone M.B.A., Sinha Y.N., Blount P., et al. Virus-induced alterations in homeostasis: alteration in differentiated functions of infected cells in vivo. Science 1982, 218:1125-1127.
141. Overman J.R. Viremia in human mumps virus infections. AMA Arch Intern Med 1958, 102:354-356.
142. Pachter J.S., De Vries H.E., Fabry Z. The blood-brain barrier and its role in immune privilege in the central nervous system. J Neuropathol Exp Neurol 2003, 62:593-604.
143. Paessler S., Ni H., Petrakova O., et al. Replication and clearance of Venezuelan equine encephalitis virus from the brains of animals vaccinated with chimeric SIN/VEE viruses. J Virol 2006, 80:2784-2796.
144. Paessler S., Yun N.E., Judy B.M., et al. Alpha-beta T cells provide protection against lethal encephalitis in the murine model of VEEV infection. Virology 2007, 367:307-323.
145. Palese P., Shaw M.L. Orthomyxoviridae: The viruses and their replication. Fields virology 2007, 1647-1689. Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia. 5th edn. D.M. Knipe, P.M. Howley, D.E. Griffin (Eds.).
146. Parra B., Hinton D.R., Marten N.W., et al. IFN-γ is required for viral clearance from central nervous system oligodendroglia. J Immunol 1999, 162:1641-1647.
147. Patterson C.E., Lawrence D.M.P., Echols L.A., et al. Immune-mediated protection from measles virus-induced central nervous system disease is noncytolytic and gamma interferon dependent. J Virol 2002, 76:4497-4506.
148. Pedemonte E., Mancardi G., Giunti D., et al. Mechanisms of the adaptive immune response inside the central nervous system during inflammatory and autoimmune diseases. Pharmacol Ther 2006, 111:555-566.
149. Podack E.R., Konigsberg P.J. Cytolytic T cell granules. Isolation, structural, biochemical, and functional characterization. J Exp Med 1984, 160:695-710.
150. Podack E.R., Young J.D.E., Cohn Z.A. Isolation and biochemical and functional characterization of perforin 1 from cytolytic T-cell granules. Proc Natl Acad Sci U S A 1985, 82:8629-8633.
151. Poluektova L., Gorantla S., Faraci J., et al. Neuroregulatory events follow adaptive immune-mediated elimination of HIV-1-infected macrophages: studies in a murine model of viral encephalitis. J Immunol 2004, 172:7610-7617.
152. Prendergast C.T., Anderton S.M. Immune cell entry to central nervous system - current understanding and prospective therapeutic targets. Endocr Metab Immune Disord Drug Targets 2009, 9:315-327.
153. Racaniello V.R. Picornaviridae: The viruses and their replication. Fields virology 2007, 795-838. Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia. 5th edn. D.M. Knipe, P.M. Howley, D.E. Griffin (Eds.).
154. Ramakrishna C., Stohlman S.A., Atkinson R.D., et al. Mechanisms of central nervous system viral persistence: the critical role of antibody and B cells. J Immunol 2002, 168:1204-1211.
155. Ramakrishna C., Bergmann C.C., Atkinson R., et al. Control of central nervous system viral persistence by neutralizing antibody. J Virol 2003, 77:4670-4678.
156. Ransohoff R.M. Chemokines and chemokine receptors: standing at the crossroads of immunobiology and neurobiology. Immunity 2009, 31:711-721.
157. Rempel J.D., Murray S.J., Meisner J., et al. Differential regulation of innate and adaptive immune responses in viral encephalitis. Virology 2004, 318:381-392.
158. Roizman B., Knipe D.M., Whitley R.J. Herpes simplex viruses. Fields virology 2007, 2501-2601. Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia. 5th edn. D.M. Knipe, P.M. Howley, D.E. Griffin (Eds.).
159. Romanowski V., Bishop D.H.L. Conserved sequences and coding of two strains of lymphocytic choriomeningitis virus (WE and ARM) and Pichinde arenavirus. Virus Res 1985, 2:35-51.
160. Romanowski V., Matsuura Y., Bishop D.H.L. Complete sequence of the S RNA of lymphocytic choriomeningitis virus (WE strain) compared to that of Pichinde arenavirus. Virus Res 1985, 3:101-114.
161. Roush S.W., Murphy T.V. Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States (The Vaccine-Preventable Disease Table Working Group). JAMA 2007, 298:2155-2163.
162. Roy A., Phares T.W., Koprowski H., et al. Failure to open the blood-brain barrier and deliver immune effectors to central nervous system tissues leads to the lethal outcome of silver-haired bat rabies virus infection. J Virol 2007, 81:1110-1118.
163. Rubin S.A., Carbone K.M. Mumps virus. Clinical neurovirology 2003, 431-445. Marcel Dekker, New York. A. Nath, J.R. Berger (Eds.).
164. Sadiq S.A., Ladoulis C.T., McKendall R.R. Humoral immune response to virus infection. Handbook of clinical neurology 1989, 51-64. Elsevier Science, Amsterdam. P.J. Vinken, G.W. Bruyn, H.L. Klawans (Eds.).
165. Satou Y., Matsuoka M. HTLV-1 and the host immune system: How the virus disrupts immune regulation, leading to HTLV-1 associated diseases. J Clin Exp Hematop 2010, 50:1-8.
166. Savarin C., Bergmann C.C. Neuroimmunology of central nervous system viral infections: the cells, molecules and mechanisms involved. Curr Opin Pharmacol 2008, 8:472-479.
167. Schneider-Schaulies J., Niewiesk S., Schneider-Schaulies S., et al. Measles virus in the CNS: the role of viral and host factors for the establishment and maintenance of a persistent infection. J Neurovirol 1999, 5:613-622.
168. Schneider-Schaulies J., ter Meulen V., Schneider-Schaulies S. Measles infection of the central nervous system. J Neurovirol 2003, 9:247-252.
169. Serafini B., Rosicarelli B., Magliozzi R., et al. Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. Brain Pathol 2004, 14:164-174.
170. Sheridan P.A., Beck M.A. The dendritic and T cell responses to herpes simplex virus-1 are modulated by dietary vitamin E. Free Radic Biol Med 2009, 46:1581-1588.
171. + T cells require perforin to clear West Nile virus from infected neurons. J Virol 2006, 80:119-129.
172. Slifka M.K., Matloubian M., Ahmed R. Bone marrow is a major site of long-term antibody production after acute viral infection. J Virol 1995, 69:1895-1902.
173. Slifka M.K., Antia R., Whitmire J.K., et al. Humoral immunity due to long-lived plasma cells. Immunity 1998, 8:363-372.
174. Smith D.M., Zárate S., Shao H., et al. Pleocytosis is associated with disruption of HIV compartmentalization between blood and cerebral spinal fluid viral populations (HNRC Group). Virology 2009, 385:204-208.
175. Spudich S.S., Nilsson A.C., Lollo N.D., et al. Cerebrospinal fluid HIV infection and pleocytosis: relation to systemic infection and antiretroviral treatment. BMC Infect Dis 2005, 5:98.
176. Steel C.D., Hahto S.M., Ciavarra R.P. Peripheral dendritic cells are essential for both the innate and adaptive antiviral immune responses in the central nervous system. Virology 2009, 387:117-126.
177. Stevenson P.G., Hawke S., Sloan D.J., et al. The immunogenicity of intracerebral virus infection depends on anatomical site. J Virol 1997, 71:145-151.
178. Streilein J.W. Interview about immune privilege with J. Wayne Streilein. Mod Asp Immunobiol 2003, 3:14.
179. Tan C.S., Koralnik I.J. Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis. Lancet Neurol 2010, 9:425-437.
180. Tenembaum S., Chitnis T., Ness J., et al. Acute disseminated encephalomyelitis. Neurology 2007, 68(Suppl 2):S23-S36.
181. Theil D., Arbusow V., Derfuss T., et al. Prevalence of HSV-1 LAT in human trigeminal, geniculate and vestibular ganglia and its implication for cranial nerve syndromes. Brain Pathol 2001, 11:408-413.
182. Theil D., Derfuss T., Paripovic I., et al. Latent herpesvirus infection in human trigeminal ganglia causes chronic immune response. Am J Pathol 2003, 163:2179-2184.
183. + T-cell response in an immune-privileged organ. J Virol 2009, 83:20-28.
184. Tishon A., Eddleston M., de la Torre J.C., et al. Cytotoxic T lymphocytes cleanse viral gene products from individually infected neurons and lymphocytes in mice persistently infected with lymphocytic choriomeningitis virus. Virology 1993, 197:463-467.
185. Townsend J.J., Stroop W.G., Baringer J.R., et al. Neuropathology of progressive rubella panencephalitis after childhood rubella. Neurology 1982, 32:185-190.
186. Trandem K., Anghelina D., Zhao J., et al. Regulatory T cells inhibit T cell proliferation and decrease demyelination in mice chronically infected with a coronavirus. J Immunol 2010, 184:4391-4400.
187. Tschen S.-I., Bergmann C.C., Ramakrishna C., et al. Recruitment kinetics and composition of antibody-secreting cells within the central nervous system following viral encephalomyelitis. J Immunol 2002, 168:2922-2929.
188. Tschen S.-I., Stohlman S.A., Ramakrishna C., et al. CNS viral infection diverts homing of antibody-secreting cells from lymphoid organs to the CNS. Eur J Immunol 2006, 36:603-612.
189. Tsunoda I., Tanaka T., Fujinami R.S. Regulatory role of CD1d in neurotropic virus infection. J Virol 2008, 82:10279-10289.
190. Unanue E.R. Antigen-binding cells. I. Their idenification and role in the immune response. J Immunol 1971, 107:1168-1174.
191. Waldschmidt T.J., Noelle R.J. Immunology. Long live the mature B cell - a BAFFling mystery resolved. Science 2001, 293:2012-2013.
192. Walters C.S., Wigzell H. Demonstration of heavy and light chain antigenic determinants on the cell-bound receptor for antigen. Similarities between membrane-attached and humoral antibodies produced by the same cell. J Exp Med 1970, 132:1233-1249.
193. Wang T., Fikrig E. Immunity to West Nile virus. Curr Opin Immunol 2004, 16:519-523.
194. Wang T., Scully E., Yin Z., et al. IFN-γ-producing γδ T cells help control murine West Nile virus infection. J Immunol 2003, 171:2524-2531.
195. Wang T., Town T., Alexopoulou L., et al. Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat Med 2004, 10:1366-1373.
196. Webster W.S. Teratogen update: congenital rubella. Teratology 1998, 58:13-23.
197. Wetz K. Attachment of neutralizing antibodies stabilizes the capsid of poliovirus against uncoating. Virology 1993, 192:465-472.
198. + T cell exhaustion during chronic viral infection. Immunity 2007, 27:670-684.
199. White F.A., Ishaq M., Stoner G.L., et al. JC virus DNA is present in many human brain samples from patients without progressive multifocal leukoencephalopathy. J Virol 1992, 66:5726-5734.
200. Wolinsky J.S. Subacute sclerosing panencephalitis, progressive rubella panencephalitis, and multifocal leukoencephalopathy. Res Publ Assoc Res Nerv Ment Dis 1990, 68:259-268.
201. Wolinsky J.S., Klassen T., Baringer J.R. Persistence of neuroadapted mumps virus in brains of newborn hamsters after intraperitoneal inoculation. J Infect Dis 1976, 133:260-267.
202. Wolinsky J.S., Waxham M.N., Hess J.L., et al. Immunochemical features of a case of progressive rubella panencephalitis. Clin Exp Immunol 1982, 48:359-366.
203. + T cells provide protection against acute lethal encephalitis caused by Venezuelan equine encephalitis virus. Vaccine 2009, 27:4064-4073.
204. Zacks M.A., Paessler S. Encephalitic alphaviruses. Vet Microbiol 2010, 140:281-286.
205. Zhou J., Stohlman S.A., Hinton D.R., et al. Neutrophils promote mononuclear cell infiltration during viral-induced encephalitis. J Immunol 2003, 170:3331-3336.
206. Zinkernagel R.M., Bachmann M.F., Kündig T.M., et al. On immunological memory. Annu Rev Immunol 1996, 14:333-367.